(Q77416953)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765398%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Reading between the lines: direct-to-consumer advertising of genetic testing in the USA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765398%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

S C Hull

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765398%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

K Prasad

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765398%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765398%20AND%20SRC:MED&resulttype=core&format=json

Reproductive Health Matters

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765398%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765398%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765398%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

44-48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765398%20AND%20SRC:MED&resulttype=core&format=json

Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

The genetic attributable risk of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

Direct to consumer drug advertising is billion dollar business in US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

Direct-to-consumer marketing of prescription drugs: creating consumer demand

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

7 January 2021

Unusual case of Smith-Lemli-Opitz syndrome "type II"

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

7 January 2021

Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

7 January 2021

Breast cancer: the high-risk mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

7 January 2021

Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

7 January 2021

Breast cancer in carriers of BRCA1 and BRCA2 mutations: tackling a molecular and clinical conundrum

1 reference

https://api.crossref.org/works/10.1016%2FS0968-8080%2801%2990089-8

7 January 2021

10.1016/S0968-8080(01)90089-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765398%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference